Reach Us +1-217-403-9671
Emerging Issues & Challenges In Pharma Education And Training System: An Overview | 7558
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Emerging issues & challenges in pharma education and Training system: An overview

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Rajashri Ojha and Shivanand P. Puthli

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Declining employability of pharma or science graduates like B.Pharm, M.Pharm, M.Sc, or M.Tech and falling standards of pharma education in India is a growing concern to all the stakeholders. Since last recession of 2008-09 the symptoms are more visible. Employers complain of not getting ?right man for right job?, failing entry level remunerations and sliding glamour of Pharmaceutical education in students. The employers?, parents? and the students? expectations are perhaps the same. The employers want ?job-ready? candidates; while parents want that their wards-students to be ?job-ready? at the end of the course. But everyone knows that this is just not happening. Barring the IIMs and exceptionally few prominent and serious top ranking B-schools in India, the large populous of universities affiliated management institutes, AICTE recognized institutes and UGC approved institutes are churning hoard of Management, and Pharm D students who do not seem to possess expected knowledge and skills to manage the business. The reasons and issues for this consequence are many. The structure of contents of syllabus, teachers with no business experience, no provision for practical experience, paucity of funds with self-funded management institutions, lack of industry interaction, theoretical nature of assessment of students are issues which hamper the quality of management science education in India today. Continuous improvement of structure of syllabus and contents as per requirement of the business, employing teachers only with business / industry experience, tuning theoretical contents with practical orientation, increasing the toughness level of assessment of students to find out their ability to analyze the real-life business circumstances and synthesize the solutions. Continuous knowledge improvement programs with mandatory industry internship / projects for teachers, are few measures to improve the quality of pharma education in India. In the process of reforming and upgrading the system of pharma education, the real issues concerning the higher level education like Regulatory and IPR required as per current industrial norms are often sidelined by the policy makers.
Mrs. Rajashri Survase-Ojha has completed her B.Pharm from Bombay College of Pharmacy with post graduate Diplomas in IPR, ADPQAM, CTDeCTD and pursuing PhD from JJT University, Rajasthan. She is a Director and Founder of Raaj Global Pharma Regulatory Affairs Consultants, Thane- Mumbai(India). She has published more than 6 Articles and papers in reputed journals. She is a competent Regulatory Affair professional with 20 years of work experience in the pharmaceutical industry like Novartis-OTC, Glenmark , GSK-TCS, Sandoz Pvt. Ltd, Famycare, local FDA and Unichem laboratories since 1991. Significant experience in Registration of pharmaceutical product & Regulatory Approvals; inclusive of IND/ NDA/ANDA/ANDs submission to different national & International Health Authorities. Faced Regulatory Audits for USFDA, UK-MHRA, EdQM, WHO and other local Audits.